PULSE BIOSCIENCES, INC. — Director's Dealing 2023

Dec 6, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2023-12-01

Reporting Person: DUGGAN ROBERT W (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-12-01	Common Stock	P	45600	$9.07	Acquired	258544	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	36551461	Direct
Common Stock	492069	Indirect

Footnotes

F1: Volume-weighted average price.

F2: Shares are held by Blazon Corporation, of which the Reporting Person is the majority shareholder.

F3: Shares are held by Genius Inc., of which the Reporting Person is the sole shareholder.